27845771|t|The Novel miR-9600 Suppresses Tumor Progression and Promotes Paclitaxel Sensitivity in Non-small-cell Lung Cancer Through Altering STAT3 Expression
27845771|a|MicroRNAs have been identified to be involved in center stage of cancer biology. They accommodate cell proliferation and migration by negatively regulate gene expression either by hampering the translation of targeted mRNAs or by promoting their degradation. We characterized and identified the novel miR-9600 and its target in human non-small-cell lung cancer (NSCLC). Our results demonstrated that the miR-9600 were downregulated in NSCLC tissues and cells. It is confirmed that signal transducer and activator of transcription 3 (STAT3), a putative target gene, is directly inhibited by miR-9600. The miR-9600 markedly suppressed the protein expression of STAT3, but with no significant influence in corresponding mRNA levels, and the direct combination of miR-9600 and STAT3 was confirmed by a luciferase reporter assay. miR-9600 inhibited cell growth, hampered expression of cell cycle -related proteins and inhibited cell migration and invasion in human NSCLC cell lines. Further, miR-9600 significantly suppressed tumor growth in nude mice. Similarly, miR-9600 impeded tumorigenesis and metastasis through directly targeting STAT3. Furthermore, we identified that miR-9600 augmented paclitaxel and cisplatin sensitivity by downregulating STAT3 and promoting chemotherapy - induced apoptosis. These data demonstrate that miR-9600 might be a useful and novel therapeutic target for NSCLC.
27845771	10	18	miR-9600	T114,T123	C1101610
27845771	19	29	Suppresses	T169	C1260953
27845771	30	47	Tumor Progression	T191	C0178874
27845771	61	71	Paclitaxel	T109,T121	C0144576
27845771	72	83	Sensitivity	T080	C0205556
27845771	87	113	Non-small-cell Lung Cancer	T191	C0007131
27845771	122	130	Altering	T078	C1515926
27845771	131	136	STAT3	T028	C1367307
27845771	137	147	Expression	T045	C0017262
27845771	148	157	MicroRNAs	T114,T123	C1101610
27845771	168	178	identified	T080	C0205396
27845771	197	209	center stage	T201	C1300072
27845771	213	227	cancer biology	T091	C1516164
27845771	246	264	cell proliferation	T043	C0596290
27845771	269	278	migration	T043	C1622501
27845771	282	292	negatively	T033	C0205160
27845771	293	317	regulate gene expression	T045	C0017263
27845771	342	353	translation	UnknownType	C0678935
27845771	357	371	targeted mRNAs	T114,T123	C0035696
27845771	394	405	degradation	T169	C0243125
27845771	410	423	characterized	T052	C1880022
27845771	428	438	identified	T080	C0205396
27845771	449	457	miR-9600	T114,T123	C1101610
27845771	466	472	target	T169	C1521840
27845771	476	481	human	T016	C0086418
27845771	482	508	non-small-cell lung cancer	T191	C0007131
27845771	510	515	NSCLC	T191	C0007131
27845771	552	560	miR-9600	T114,T123	C1101610
27845771	566	579	downregulated	T044	C0013081
27845771	583	588	NSCLC	T191	C0007131
27845771	589	596	tissues	T024	C0040300
27845771	601	606	cells	T025	C0007634
27845771	629	679	signal transducer and activator of transcription 3	T028	C1367307
27845771	681	686	STAT3	T028	C1367307
27845771	691	711	putative target gene	T028	C0017337
27845771	725	734	inhibited	T080	C0311403
27845771	738	746	miR-9600	T114,T123	C1101610
27845771	752	760	miR-9600	T114,T123	C1101610
27845771	770	780	suppressed	T169	C1260953
27845771	785	803	protein expression	T045	C1171362
27845771	807	812	STAT3	T028	C1367307
27845771	823	837	no significant	T033	C3694175
27845771	838	847	influence	T077	C4054723
27845771	865	869	mRNA	T114,T123	C0035696
27845771	870	876	levels	T080	C0441889
27845771	908	916	miR-9600	T114,T123	C1101610
27845771	921	926	STAT3	T028	C1367307
27845771	973	981	miR-9600	T114,T123	C1101610
27845771	982	991	inhibited	T080	C0311403
27845771	992	1003	cell growth	T043	C0007595
27845771	1014	1024	expression	T045	C1171362
27845771	1028	1038	cell cycle	T043	C0007586
27845771	1048	1056	proteins	T116,T123	C0033684
27845771	1061	1070	inhibited	T080	C0311403
27845771	1071	1085	cell migration	T043	C1622501
27845771	1090	1098	invasion	T046	C2699153
27845771	1102	1107	human	T016	C0086418
27845771	1108	1113	NSCLC	T191	C0007131
27845771	1114	1124	cell lines	T025	C0085983
27845771	1135	1143	miR-9600	T114,T123	C1101610
27845771	1158	1168	suppressed	T169	C1260953
27845771	1169	1181	tumor growth	T191	C0598934
27845771	1185	1194	nude mice	T015	C0025932
27845771	1207	1215	miR-9600	T114,T123	C1101610
27845771	1224	1237	tumorigenesis	T191	C0007621
27845771	1242	1252	metastasis	T046	C4255448
27845771	1270	1279	targeting	T044	C1148560
27845771	1280	1285	STAT3	T028	C1367307
27845771	1303	1313	identified	T080	C0205396
27845771	1319	1327	miR-9600	T114,T123	C1101610
27845771	1338	1348	paclitaxel	T109,T121	C0144576
27845771	1353	1362	cisplatin	T121,T197	C0008838
27845771	1363	1374	sensitivity	T080	C0205556
27845771	1378	1392	downregulating	T044	C0013081
27845771	1393	1398	STAT3	T028	C1367307
27845771	1413	1425	chemotherapy	T061	C3665472
27845771	1428	1435	induced	T169	C0205263
27845771	1436	1445	apoptosis	T043	C0162638
27845771	1475	1483	miR-9600	T114,T123	C1101610
27845771	1512	1523	therapeutic	T169	C0302350
27845771	1524	1530	target	T169	C1521840
27845771	1535	1540	NSCLC	T191	C0007131